• Targeting BCL-XL and MCL-1 in Glioblastoma via BH3-Mimetics

  2026-06-23

  Koessinger et al. reveal that glioblastoma exhibits increased apoptotic priming due to elevated BCL-XL and MCL-1 expression, making these tumors particularly sensitive to BH3-mimetic inhibitors. Their study demonstrates that sequential targeting of BCL-XL and MCL-1 induces robust anti-tumor responses in preclinical models, informing new strategies for overcoming therapeutic resistance in GBM.

• HyperTrap Heparin HP Column: Unpacking Ligand Density and Se

  2026-06-23

  Explore how the HyperTrap Heparin HP Column leverages high ligand density and refined agarose chemistry for advanced purification of growth factors and nucleic acid enzymes. Gain unique insight into optimizing selectivity for CCR7–Notch1 stemness pathway research.

• Pharmacokinetics of CSBTA in MASH: Tissue Distribution and V

  2026-06-22

  The referenced study systematically investigates how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetic behavior and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in a mouse model. By elucidating the interplay between disease pathology, drug-metabolizing enzymes, and transporters, the work provides concrete insights for optimizing dosing regimens in MASH interventions.

• Intravesical p21 mRNA-LNPs for Localized Bladder Cancer Ther

  2026-06-22

  This study demonstrates a non-viral, intravesical delivery strategy using p21 mRNA-loaded lipid nanoparticles for targeted tumor suppressor replacement in bladder cancer. The approach enables robust, localized p21 restoration and tumor growth suppression, offering a clinically relevant alternative to existing therapies.

• Spermine in Cellular Metabolism Research: Protocols & Innova

  2026-06-21

  Spermine, a pivotal endogenous polyamine, is redefining cellular metabolism and ion channel modulation workflows. This article bridges foundational protocols with the latest insights from membrane fusion research, empowering scientists with actionable parameters and troubleshooting strategies.

• Atorvastatin: HMG-CoA Reductase Inhibitor in Cancer & Vascul

  2026-06-20

  APExBIO’s Atorvastatin enables advanced workflows for dissecting cholesterol metabolism and ferroptosis-driven cancer biology. This article delivers stepwise protocols, troubleshooting strategies, and actionable insights, drawing on recent breakthroughs in hepatocellular carcinoma research to empower translational scientists.

• Proteinase K: Broad-Spectrum Serine Protease for DNA Integri

  2026-06-19

  Proteinase K from APExBIO delivers unmatched DNA integrity during protein hydrolysis, outperforming conventional proteases in complex molecular workflows. Its robust activity enables reliable genomic DNA isolation and enzyme contaminant removal even under challenging sample conditions.

• Capsaicin-Induced Autophagy Protects BMSCs in Oxidative Stre

  2026-06-19

  This study reveals that capsaicin activates autophagy in bone marrow stromal cells (BMSCs) via TRPV1-mediated calcium influx and downregulation of the PI3K/AKT/mTOR pathway, enhancing BMSC survival and osteogenic differentiation under oxidative stress. The findings provide mechanistic insight for osteoporosis research and suggest new approaches for improving BMSC function in challenging environments.

• LMTK2 Modulates Inflammation in LPS-Stimulated Microglia via

  2026-06-18

  Rui et al. reveal that Lemur tyrosine kinase 2 (LMTK2) regulates neuroinflammatory responses in LPS-activated BV2 microglia through modulation of the Nrf2/HO-1/NQO1 pathway. Their work clarifies LMTK2’s potential as a molecular target in neuroinflammation, with implications for developing new interventions in neurodegenerative disease models.

• D-N-Acetylgalactosamine: Technical Use in Brain Glycoprotein

  2026-06-18

  D-N-Acetylgalactosamine is a high-purity, water-soluble metabolite designed to support precise glycoprotein constituent analysis in neurological workflows, particularly for brain heteropolysaccharides and glycosylation pathway studies. It is not suitable for protocols requiring ethanol solubility or for applications needing long-term storage of prepared solutions, and strict adherence to storage and handling parameters is essential for data reliability.

• Steroid-Induced Lysis of Bacterial Protoplasts: Mechanisms a

  2026-06-17

  Smith and Shay's 1965 study innovatively used bacterial protoplasts to dissect the membrane-targeting actions of synthetic steroids and their antagonists. The findings clarify how direct membrane disruption, rather than cell wall interaction, underlies the antimicrobial effects of these compounds, offering protocols for membrane-based antimicrobial studies.

• Fingolimod (FTY720): Mechanisms, Benchmarks, and MS Applicat

  2026-06-17

  Fingolimod (FTY720) is an orally active sphingosine-1-phosphate receptor modulator used for multiple sclerosis. It inhibits lymphocyte egress and upregulates neuroprotective factors, with well-characterized pharmacokinetics and cytotoxicity profiles. The compound's efficacy and limitations are supported by peer-reviewed studies and APExBIO's validated product documentation.

• Fingolimod (FTY720): Data-Driven Solutions for Cell Assays

  2026-06-16

  This article addresses real laboratory challenges with cell viability and immune modulation assays, providing evidence-based guidance on using Fingolimod (FTY720), SKU A8548. By grounding recommendations in quantitative data and peer-reviewed literature, it demonstrates how APExBIO’s high-purity Fingolimod enables reproducible, cost-effective, and robust workflows for biomedical researchers.

• LG 101506: Precision RXR Modulator for Immunometabolic Resea

  2026-06-16

  LG 101506 empowers researchers to dissect RXR signaling with unmatched specificity, enabling advanced studies in immune checkpoint regulation and metabolic disease modeling. Proven in challenging cellular systems, this RXR modulator from APExBIO delivers consistent performance for both discovery and translational workflows.

• AI-Driven Discovery of Senolytics: Innovation and Implicatio

  2026-06-15

  This article analyzes a recent study that applied machine learning to identify novel senolytic agents, offering a significant advance in the targeted elimination of senescent cells. The approach demonstrates both the efficiency of computational drug screening and its potential to accelerate cancer and aging research.

16648 records 1/1110 page Next 12345 下5页 Last page